GB2227936A - Vaccine against brucella abortus - Google Patents

Vaccine against brucella abortus

Info

Publication number
GB2227936A
GB2227936A GB8921650A GB8921650A GB2227936A GB 2227936 A GB2227936 A GB 2227936A GB 8921650 A GB8921650 A GB 8921650A GB 8921650 A GB8921650 A GB 8921650A GB 2227936 A GB2227936 A GB 2227936A
Authority
GB
United Kingdom
Prior art keywords
brucella abortus
vaccine against
against brucella
vaccine
abortus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8921650A
Other versions
GB8921650D0 (en
GB2227936B (en
Inventor
Leslie G Adams
Richard P Crawford
Donald S Davis
Thomas A Ficht
Iii Roger Smith
Blair A Sowa
Joe W Templeton
John D Williams
Albert W Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University System
Original Assignee
Texas A&M University System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University System filed Critical Texas A&M University System
Publication of GB8921650D0 publication Critical patent/GB8921650D0/en
Publication of GB2227936A publication Critical patent/GB2227936A/en
Application granted granted Critical
Publication of GB2227936B publication Critical patent/GB2227936B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/23—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Brucella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

The present invention relates to an improved vaccine against Brucella abortus. Specifically, the invention is a novel vaccine in which specific antigens of Brucella abortus are combined to induce an immunological response which provides protective immunity yet permits differentiation between field strain infected and vaccinated cattle.
GB8921650A 1987-03-30 1988-03-29 Vaccine against brucella abortus Expired - Fee Related GB2227936B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3218387A 1987-03-30 1987-03-30
PCT/US1988/001000 WO1988007374A1 (en) 1987-03-30 1988-03-29 Vaccine against brucella abortus

Publications (3)

Publication Number Publication Date
GB8921650D0 GB8921650D0 (en) 1990-02-21
GB2227936A true GB2227936A (en) 1990-08-15
GB2227936B GB2227936B (en) 1991-09-25

Family

ID=21863555

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8921650A Expired - Fee Related GB2227936B (en) 1987-03-30 1988-03-29 Vaccine against brucella abortus

Country Status (8)

Country Link
EP (1) EP0357642A1 (en)
JP (1) JPH02503196A (en)
AU (1) AU623854B2 (en)
CA (1) CA1337269C (en)
GB (1) GB2227936B (en)
MX (1) MX166766B (en)
NZ (1) NZ224065A (en)
WO (1) WO1988007374A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903414A (en) * 1990-07-06 1992-01-07 Kansanterveyslaitos PRODUKTION AV PROTEINER I GRAMPOSITIVA BAKTERIER.
WO1993016728A1 (en) * 1992-02-25 1993-09-02 The Texas A & M University System Improved vaccin against brucella abortus
AU704821B2 (en) * 1994-11-25 1999-05-06 Innogenetics N.V. New 17-KDA brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
US7364745B2 (en) * 2004-02-06 2008-04-29 Virginia Tech Intellectual Properties, Inc. Development of a live, attenuated, recombinant vaccine for Brucellosis
GB0724668D0 (en) * 2007-12-19 2008-01-30 Secr Defence Vaccines for Brucellosis
CN104862242B (en) * 2015-03-20 2018-03-16 中国食品药品检定研究院 A kind of Brucella vaccine
CN105693831B (en) * 2016-02-06 2019-01-11 内蒙古农业大学 A kind of detection reagent and its application of brucella S2 vaccine immunity antibody
CN114073762B (en) * 2020-08-12 2023-07-21 中国人民解放军军事科学院军事医学研究院 Brucella bi-component vaccine containing Omp19 and VirB8 proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Biological Abstracts/RRM *
Chemical Abstracts, volu *
Gene, volume 63, no.1, 1 *

Also Published As

Publication number Publication date
GB8921650D0 (en) 1990-02-21
AU623854B2 (en) 1992-05-28
CA1337269C (en) 1995-10-10
NZ224065A (en) 1991-02-26
WO1988007374A1 (en) 1988-10-06
AU1573288A (en) 1988-11-02
EP0357642A1 (en) 1990-03-14
GB2227936B (en) 1991-09-25
MX166766B (en) 1993-02-03
JPH02503196A (en) 1990-10-04

Similar Documents

Publication Publication Date Title
HU9402261D0 (en) Urease-based vaccine against helicobacter infection
GB2210557B (en) Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant.
NZ512574A (en) Novel streptococcus antigens useful as vaccines
IL107026A0 (en) Antigen of hybrid m protein and carrier for group a streptococcal vaccine
ES500567A0 (en) PROCEDURE FOR PREPARING VACCINATION COMPLEXES BY REACTION OF RIBONOSAL RNA AND SPECIFIC ANTIGENS.
SG46445A1 (en) Vaccines against cancer and infectious diseases
ATE295895T1 (en) GENETIC VACCINE AGAINST THE IMMUNO DEFICIENCY VIRUS
DE68929323D1 (en) PNEUMOLYSIN MUTANTS AND PNEUMOCOCCAL VACCINES THEREOF
PH25776A (en) Pseudorabies virus mutants incapable of producing glycoprotein x
AU1013601A (en) Method of inducing and/or enhancing an immune response to tumor antigens
HUP9801223A2 (en) Method for enhancing the antibody response to specific antigens with interleukin-10
AU5941486A (en) Tetanus vaccine from cloned antigen
GB2227936A (en) Vaccine against brucella abortus
MY105080A (en) Heat-labile toxin b subunit fusion proteins.
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
MX9603124A (en) Mild newcastle disease virus vaccine.
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
PL341541A1 (en) Isolated strains of staphyloccoccus aureus and vaccines prepared of them
GB2144129B (en) Antigens as immunostimulant adjuvants
EP0693936A4 (en) CLONED -i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
Lu et al. Studies on the Immunological and Serological Identification of Spotted Fever Group Rickettsiae.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
CS850087A1 (en) Inactivated vaccine against salmonellosis of calves

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940329